A systematic analysis of UK cancer research funding by gender of primary investigator.

Autor:	Zhou CD; Department of Nuclear Medicine, Royal Free NHS Foundation Trust, London, UK., Head MG; Faculty of Medicine, Institute for Life Sciences, Global Health Research Institute, University of Southampton, Southampton, UK., Marshall DC; Oxford University Clinical Academic Graduate School, John Radcliffe Hospital, Oxford, UK., Gilbert BJ; Department of Economics, University of Oxford, Oxford, UK., El-Harasis MA; Faculty of Medicine, Imperial College London, London, UK., Raine R; Department of Applied Health Research, University College London, London, UK., O'Connor H; School of Media, Communication and Sociology, University of Leicester, Leicester, UK., Atun R; Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Maruthappu M; Department of Epidemiology and Public Health, University College London, London, UK.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2018 Apr 30; Vol. 8 (4), pp. e018625. Date of Electronic Publication: 2018 Apr 30.
DOI:	10.1136/bmjopen-2017-018625
Abstrakt:	Objectives: To categorically describe cancer research funding in the UK by gender of primary investigator (PIs). Design: Systematic analysis of all open-access data. Methods: Data about public and philanthropic cancer research funding awarded to UK institutions between 2000 and 2013 were obtained from several sources. Fold differences were used to compare total investment, award number, mean and median award value between male and female PIs. Mann-Whitney U tests were performed to determine statistically significant associations between PI gender and median grant value. Results: Of the studies included in our analysis, 2890 (69%) grants with a total value of £1.82 billion (78%) were awarded to male PIs compared with 1296 (31%) grants with a total value of £512 million (22%) awarded to female PIs. Male PIs received 1.3 times the median award value of their female counterparts (P<0.001). These apparent absolute and relative differences largely persisted regardless of subanalyses. Conclusions: We demonstrate substantial differences in cancer research investment awarded by gender. Female PIs clearly and consistently receive less funding than their male counterparts in terms of total investment, the number of funded awards, mean funding awarded and median funding awarded. Competing Interests: Competing interests: None declared. (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu